Thyrocare Technologies IPO listing price is ₹ 618.10, issue price is [●], and currently trading at ₹ 962.35 as on May 22, 2025. Thyrocare Technologies IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Thyrocare Technologies IPO is a Book Building listing on BSE,NSE exchange. The company is based in Mumbai and caters to Healthcare sector. Edelweiss Financial Services , ICICI Securities , Jm Financial are the merchant bankers of Thyrocare Technologies IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on [●].
Thyrocare Technologies IPO offer price is ₹ 446.00 and got listed at ₹ 618.10. Read Thyrocare Technologies IPO details mentioned above.The IPO of Thyrocare Technologies Limited was listed on 9th May 2016. As of today, Thyrocare Technologies IPO is trading at ₹ 962.35, compared to the previous day’s close of ₹ 979.65. Read the report above for detailed IPO performance.
The issue price of Thyrocare Technologies IPO was [●] per equity share.
Thyrocare Technologies IPO was listed at ₹618.10 on the stock exchange on 9th May 2016. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of May 22, 2025, the current market price of Thyrocare Technologies IPO is ₹ 962.35.
The 52-week high for Thyrocare Technologies IPO is ₹ 1055.00, while the 52-week low is ₹ 571.40. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Thyrocare Technologies IPO listed at ₹ 618.10 against the issue price of [●] per equity share, showing a listing day gain/loss of 172.1 (38.59%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Thyrocare Technologies IPO stock moved from its listing price of ₹ 618.10 to the current price of ₹962.35 per equity share, reflecting a change of 55.69% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Thyrocare Technologies IPO issue date of May 22, 2025 and CMP of ₹962.35, the estimated CAGR is approximately 8.87%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Thyrocare Technologies IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Thyrocare Technologies Financial Review Page
Merchant Banker(s) of Thyrocare Technologies IPO: Edelweiss Financial Services Limited , ICICI Securities Limited , Jm Financial Limited
Thyrocare Technologies IPO subscription was 73.55 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Thyrocare Technologies IPO listed at a listing price of 618.10 against the offer price of 446.00.
The current market price of Thyrocare Technologies is 962.35.
Why Us?